По вашему запросу найдено документов: 68

Страница 4 из 7

The Role of Hydrogen Sulfide in the Localization and Expression of p53 and Cell Death in the Nervous Tissue in Traumatic Brain Injury and Axotomy
Rodkin, Stanislav, Nwosu, Chizaram, Raevskaya, Margarita, Khanukaev, Maxim, Bekova, Khava, Vasilieva, Inna, Vishnyak, Diana, Tolmacheva, Anastasia, Efremova, Elena, Gasanov, Mitkhat, Tyurin, Anton (2023)
. To date, there are no clinically effective neuroprotective drugs. In this study, we examined the role
Treatment of Metastatic Renal Cell Carcinoma with Checkpoint Inhibitors in Clinical Practice in the Volga-Ural Region of the Eurasian Continent
Rakhimov, Radmir R., Sultanbaev, Aleksandr V., Izmailov, Adel A., Menshikov, Konstantin V., Zabelin, Vadim M., Izmailov, Albert A., Izmailov, Albert A., Izmailova, Svetlana M., Bakhtiyarova, Ksenia S., Izmailova, Angelina A., Gilyazova, Irina R. (2023)
cancer by app-lying modern target drugs and immunotherapy. Results: In routine clinical practice
Role of exosomal ncRNAs in traumatic brain injury
Beylerli, Ozal, Tamrazov, Rasim, Gareev, Ilgiz, Ilyasova, Tatiana, Shumadalova, Alina, Bai, Yunlong, Yang, Baofeng (2023)
the brain parenchyma makes them attractive candidates for non-invasive biomarkers and drug delivery systems
Design, synthesis, and bioactivity evaluation of novel 1-(4-(benzylsulfonyl)-2-nitrophenyl) derivatives as potential anti-inflammatory agents against LPS-induced ac
Chen, P., Yu, Y., Su, S., Du, Z., Cai, B., Sun, X., Chattipakorn, N., Samorodov, A.V., Pavlov, V.N., Tang, Q., Cho, W.-J., Liang, G. (2023)
-inflammatory drugs to treat ALI.
Exosomal non coding RNAs as a novel target for diabetes mellitus and its complications
Sufianov, A., Kostin, A., Begliarzade, S., Kudriashov, V., Ilyasova, T., Liang, Y., Mukhamedzyanov, A., Beylerli, O. (2023)
exosomes for the diagnosis and delivery of drugs directly to target cells in DM. This study presents
SYNTHESIS AND ANTIAGGREGANT AND ANTICOAGULANT ACTIVITY OF AMINO-ACID SALTS AND COMPUTER SIMULATION OF THE INTERACTION OF THEIR STRUCTURES WITH THE SURFACE OF CYCLOOXYGENASE
Gurevich, K.G., Urakov, A.L., Purygin, P.P., Abzalilov, T.A., Garaev, T.M., Zarubin, Y.P., Afanasiev, V.A., Sakaev, V.E., Samoredov, A.V., Pavlov, V.N., Lovtsova, L.V. (2023)
Effective drugs with antiaggregant and anticoagulant activity are known to possess side effects
Новый фармаконутрицевтик Хондрогард®ТРИО для профилактики заболеваний опорно-двигательного аппарата и нутритивной поддержки пациентов с остеоартритом и неспецифической болью в спине: оценка клинических возможностей. Резолюция мультидисциплинарного экспертного совета
New pharmaconutraceutical Chondroguard®TRIO for the prevention of musculoskeletal diseases and nutritional support for patients with osteoarthritis and nonspecific back pain: an assessment of clinical options. Resolution of the Multidisciplinary Expert Council
Danilov, Al B., Lila, A.M., Majidova, Yo N., Gromova, O.A., Tkacheva, O.N., Sarvilina, I.V., Kochish, A.Yu., Nazarenko, A.G., Zagorodniy, N.V., Minasov, T.B., Alekseeva, L.I., Taskina, E.A., Kotovskaya, Yu.V., Dudinskaya, E.N., Rozanov, A.V., Solovieva, E.Yu., Shavlovskaya, O.A., Sharov, M.N., Kamchatnov, P.R., Rachin, A.P., Barantsevich, E.R., Iskra, D.A., Yakupov, E.Z., Devlikamova, F.I., Barulin, A.E., Nesterova, M.V., Sakovets, T.G., Barinov, A.N., Dolgova, I.N., Zabolotskikh, N.V., Zonova, E.V., Shchepankevich, L.A., Parfenov, V.A., Dzhurabekova, A.T., Khakimova, S.Z, Данилов Ал.Б., Лила А.М., Маджидова Ё.Н., Громова О.А., Ткачева О.Н., Сарвилина И.В., Кочиш А.Ю., Назаренко А.Г., Загородний Н.В., Минасов Т.Б., Алексеева Л.И., Таскина Е.А., Котовская Ю.В., Дудинская Е.Н., Розанов А.В., Соловьева Э.Ю., Шавловская О.А., Шаров М.Н., Камчатнов П.Р., Рачин А.П., Баранцевич Е.Р., Искра Д.А., Якупов Э.З., Девликамова Ф.И., Барулин А.Е., Нестерова М.В., Саковец Т.Г., Баринов А.Н., Долгова И.Н, Заболотских Н.В., Зонова Е.В., Щепанкевич Л.А., Парфенов В.А., Джурабекова А.Т., Хакимова С.З. (2023)
for the effectiveness and safety of the use of drugs that modify the course of OA (Disease-modifying osteoarthritis
Микробиота кишечника у детей с ювенильным идиопатическим артритом
Gut microbiota and methotrexate in children with juvenile idiopathic arthritis
Zhukov, S.S., Malievsky, V.A., Nizhevich, A.A., Жуков, С. С., Малиевский, В. А., Нижевич, А. А (2023)
An open-label extension of a phase 2 dose-finding study of once-weekly somatrogon vs. once-daily Genotropin in children with short stature due to growth hormone deficiency: results following 5 years of treatment
Zadik, Zvi, Zelinska, Nataliya, Iotova, Violeta, Skorodok, Yulia, Malievsky, Oleg, Mauras, Nelly, Valluri, Srinivas Rao, Pastrak, Aleksandra, Rosenfeld, Ron (2023)
were reported in 81.3% of participants, most unrelated to study drug. Conclusions: Up to 5 years
Перспективы эпигенетической иммунотерапии рака почки
Future of epigenetic immunotherapy in kidney cancer
Mustafin, R.N., Мустафин, Р. Н. (2023)

Страница 4 из 7

Google Scholar
OpenDoar

Фасеты

Авторы
Ключевые слова
Год